Working to make a difference in the lives of all affected by cancer.
Learn About Our Work
Explore immunotherapy discoveries, treatment approvals and milestones.
See Our Breakthroughs
Find clinical trials that match your diagnosis, stage and treatment history.
Learn more about this revolutionary cancer treatment.
Understand the Basics
Meet the CRI scientists committed to the development of immunotherapy.
Since 1953, we've led the field with support for immunotherapy research and clinical trials. Together with our donor, patient, and scientist communities, we continue to fund revolutionary breakthroughs to cure all types of cancer.
By harnessing the innate powers of the body's immune system, immunotherapy treatments have the potential to achieve complete, long-lasting remissions and cures for all types of cancer.
See how immunotherapy works
See Where Your Money Goes
Fundraise for immunotherapy
Share Stories and Connect
Become a corporate sponsor
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, 4th Floor | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
FDA approves new immunotherapy--Yescarta (axicabtagene ciloleucel)--for adult patients with relapsed or refractory non-Hodgkin large B cell lymphoma.
CRI among 12 top-rated cancer charities within a subset of organizations doing good work in breast cancer as well as other forms of cancer.